Intuitive Surgical, Inc. $ISRG Shares Bought by Baird Financial Group Inc.

Baird Financial Group Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 35.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 113,691 shares of the medical equipment provider’s stock after buying an additional 29,843 shares during the period. Baird Financial Group Inc.’s holdings in Intuitive Surgical were worth $61,781,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. First Trust Advisors LP grew its position in Intuitive Surgical by 18.3% in the second quarter. First Trust Advisors LP now owns 184,883 shares of the medical equipment provider’s stock valued at $100,467,000 after acquiring an additional 28,556 shares in the last quarter. Guggenheim Capital LLC lifted its position in shares of Intuitive Surgical by 25.1% during the second quarter. Guggenheim Capital LLC now owns 95,463 shares of the medical equipment provider’s stock worth $51,876,000 after purchasing an additional 19,163 shares in the last quarter. Kilter Group LLC purchased a new position in shares of Intuitive Surgical in the second quarter valued at $27,000. EverSource Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 30.2% in the second quarter. EverSource Wealth Advisors LLC now owns 1,750 shares of the medical equipment provider’s stock valued at $951,000 after purchasing an additional 406 shares during the period. Finally, Alpha Family Trust grew its holdings in Intuitive Surgical by 19.3% during the 2nd quarter. Alpha Family Trust now owns 2,535 shares of the medical equipment provider’s stock valued at $1,378,000 after purchasing an additional 410 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In related news, EVP Henry L. Charlton sold 13,731 shares of the business’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $7,963,980.00. Following the completion of the transaction, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 7,562 shares of the company’s stock in a transaction on Tuesday, October 28th. The stock was sold at an average price of $548.43, for a total value of $4,147,227.66. Following the transaction, the executive vice president owned 353 shares of the company’s stock, valued at approximately $193,595.79. The trade was a 95.54% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 108,939 shares of company stock valued at $60,757,995. 0.70% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on the stock. Sanford C. Bernstein reiterated an “outperform” rating and issued a $685.00 price objective on shares of Intuitive Surgical in a report on Tuesday, October 21st. Truist Financial set a $620.00 target price on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Argus boosted their price target on Intuitive Surgical from $600.00 to $630.00 in a research note on Monday, October 27th. Robert W. Baird set a $655.00 price objective on Intuitive Surgical in a research note on Wednesday, October 22nd. Finally, BTIG Research lifted their price objective on Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $607.17.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $568.63 on Friday. The company’s fifty day moving average is $515.92 and its two-hundred day moving average is $505.59. Intuitive Surgical, Inc. has a 1-year low of $425.00 and a 1-year high of $616.00. The stock has a market capitalization of $203.84 billion, a price-to-earnings ratio of 75.22, a price-to-earnings-growth ratio of 5.24 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.84 EPS. Sell-side analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.